Clinical Features and Prognostic Factors for Dermatomyositis-Associated Interstitial Lung Diseases with Anti-MDA5 Antibody

被引：0
|
作者：
Fujisawa, T. [1 ]
Hozumi, H. [1 ]
Yasui, H. [1 ]
Suzuki, Y. [1 ]
Karayama, M. [1 ]
Furuhashi, K. [1 ]
Enomoto, N. [1 ]
Nakamura, Y. [1 ]
Inui, N. [2 ]
Suda, T. [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Deparmtne Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1679
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease
    Ye, Yan
    Fu, Qiong
    Wang, Ran
    Guo, Qiang
    Bao, Chunde
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (08)
  • [42] Dermatomyositis associated with anti-MDA5 autoantibody
    Victoria Collado, Maria
    De Los Angeles Gargiulo, Maria
    Gomez, Ramiro
    Gomez, Graciela
    Perez, Nicolas
    Suarez, Lorena
    Lia Taratuto, Ana
    Aruj, Patricia
    MEDICINA-BUENOS AIRES, 2018, 78 (05) : 360 - 363
  • [43] CLINICAL FEATURES IN RECURRENCE OF ANTI-MDA5 AUTOANTIBODIES POSITIVE DERMATOMYOSITIS
    Yamaguchi, Koichi
    Yamaguchi, Aya
    Kashiwagi, Chiharu
    Masubuchi, Hiroaki
    Hara, Kenichiro
    Koga, Yasuhiko
    Sunaga, Noriaki
    Maeno, Toshiaki
    RESPIROLOGY, 2019, 24 : 81 - 82
  • [44] Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis
    Gono, Takahisa
    Kawaguchi, Yasushi
    Ozeki, Eri
    Ota, Yuko
    Satoh, Takashi
    Kuwana, Masataka
    Hara, Masako
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2011, 21 (02) : 223 - 227
  • [45] JUVENILE DERMATOMYOSITIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE: WOULD ANTI-MDA5 ANTIBODY DETECTION IMPROVE EARLY DIAGNOSIS AND MANAGEMENT?
    Gallagher, Kathy
    Bale, Peter
    Armon, Kate
    RHEUMATOLOGY, 2018, 57
  • [46] Interstitial Lung Disease-Complicated Anti-MDA5 Antibody in Clinically Amyopathic Dermatomyositis Patients: Report of Two Cases With Distinct Clinical Features
    Pacot, Laurence
    Pouchot, Jacques
    De Prost, Nicolas
    Senant, Marie
    Tartour, Eric
    Le Pimpec-Barthes, Francoise
    Israel-Biet, Dominique
    Dragon-Durey, Marie-Agnes
    FRONTIERS IN MEDICINE, 2020, 7
  • [47] The lung as a site for the generation of anti-MDA5 antibody in clinically amyopathic dermatomyositis
    Hara, Ryo
    Watanabe, Satoshi
    Terada, Nanao
    Kase, Kazumasa
    Muto, Atsushi
    Hamaguchi, Yasuhito
    Matsushita, Takashi
    Ikeda, Hiroko
    Tanaka, Tomonori
    Yano, Seiji
    RHEUMATOLOGY, 2024,
  • [48] Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review
    Takanashi, Satoshi
    Kaneko, Yuko
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2022, 32 (01) : 231 - 237
  • [49] dermatomyositis associated with anti-MDA5 antibodies: A heterogenous clinical picture
    Valero-Martinez, Cristina
    Bris, Beatriz Butron
    Castaneda, Santos
    MEDICINA CLINICA, 2022, 158 (04): : 186 - 187
  • [50] A CASE OF COVID VACCINE-ASSOCIATED ANTI-MDA5 ANTIBODY DERMATOMYOSITIS
    Woodard, Vanessa
    Mann, Blake A.
    CHEST, 2023, 164 (04) : 3327A - 3328A
12345